These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 2208080)

  • 21. Concentrations and distribution of 3,3'-dichlorobenzidine and its congeners in environmental samples from Lake Macatawa.
    Harden J; Donaldson FP; Nyman MC
    Chemosphere; 2005 Feb; 58(6):767-77. PubMed ID: 15621190
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Stimulation of the conjugation of lipid dienes in hepatic microsomes by 3,3'-dichlorobenzidine.
    Iba MM; Lang B
    Biochem Pharmacol; 1988 Mar; 37(5):781-91. PubMed ID: 3345196
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Photodechlorination of 3,3'-dichlorobenzidine in water.
    Nyman MC; Haber KS; Kenttämaa HI; Blatchley ER
    Environ Toxicol Chem; 2002 Mar; 21(3):500-6. PubMed ID: 11878462
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Induction of hepatic microsomal cytochrome P-448-mediated oxidases by 3,3'-dichlorobenzidine in the rat.
    Iba MM; Sikka HC
    Biochem Pharmacol; 1983 Mar; 32(5):901-9. PubMed ID: 6838636
    [TBL] [Abstract][Full Text] [Related]  

  • 25. 3,3'-Dichlorobenzidine and 3,3'-dichlorobenzidine dihydrochloride.
    Rep Carcinog; 2004; 11():III87-9. PubMed ID: 21089853
    [No Abstract]   [Full Text] [Related]  

  • 26. Summation effect of N-butyl-n-(4-hydroxybutyl)nitrosamine, N-(4-(5-nitro-2-furyl)-2-thiazoly)formamide, N-2-fluoroenylacetamide, and 3,3'-dichlorobenzidine on urinary bladder carcinogenesis in rats.
    Tatematsu M; Miyata Y; Mizutani M; Hananouchi M; Hirose M
    Gan; 1977 Apr; 68(2):193-202. PubMed ID: 892293
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Urinary metabolites of 3, 3'-dichlorobenzidine and their mutagenicity (author's transl)].
    Tanaka K
    Sangyo Igaku; 1981 Jul; 23(4):426-7. PubMed ID: 7321290
    [No Abstract]   [Full Text] [Related]  

  • 28. Effect of acute 3,3'-dichlorobenzidine administration on rat hepatic enzymic and nonenzymic microsomal lipid peroxidation and antioxidant status.
    Iba MM
    Res Commun Chem Pathol Pharmacol; 1987 May; 56(2):243-52. PubMed ID: 3602587
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Development and evaluation of a microtiter plate enzyme immunoassay for antibodies to 3,3'-dichlorobenzidine.
    Spierto FW; Vogt R; Whitfield W; Powell MK; Gardner FH; Hannon WH
    J Anal Toxicol; 1987; 11(1):31-5. PubMed ID: 3546934
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Species and strain differences in the hepatic cytochrome P450-mediated biotransformation of 1,4-dichlorobenzene.
    Hissink AM; Oudshoorn MJ; Van Ommen B; Van Bladeren PJ
    Toxicol Appl Pharmacol; 1997 Jul; 145(1):1-9. PubMed ID: 9221818
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Activation of 3,3'-dichlorobenzidine: enzymic basis and toxicological consequences.
    Iba MM
    Drug Metab Rev; 1989-1990; 21(3):377-400. PubMed ID: 2701169
    [No Abstract]   [Full Text] [Related]  

  • 32. NTP technical report on the toxicity and metabolism studies of chloral hydrate (CAS No. 302-17-0). Administered by gavage to F344/N rats and B6C3F1 mice.
    Beland FA
    Toxic Rep Ser; 1999 Aug; (59):1-66, A1-E7. PubMed ID: 11803702
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Molecular mechanisms of 3,3'-dichlorobenzidine-mediated toxicity in HepG2 cells.
    Chen LC; Wu JC; Tuan YF; Tseng YK; Hseu YC; Chen SC
    Environ Mol Mutagen; 2014 Jun; 55(5):407-20. PubMed ID: 24604609
    [TBL] [Abstract][Full Text] [Related]  

  • 34. 3,3'-Dichlorobenzidine and its dihydrochloride.
    National Toxicology Program
    Rep Carcinog; 2011; 12():141-3. PubMed ID: 21850145
    [No Abstract]   [Full Text] [Related]  

  • 35. Laser Irradiation of Organic Tattoo Pigments Releases Carcinogens with 3,3'-Dichlorobenzidine Inducing DNA Strand Breaks in Human Skin Cells.
    Hering H; Sung AY; Röder N; Hutzler C; Berlien HP; Laux P; Luch A; Schreiver I
    J Invest Dermatol; 2018 Dec; 138(12):2687-2690. PubMed ID: 29935208
    [No Abstract]   [Full Text] [Related]  

  • 36. Effect of storage at 4 degrees on prepared Salmonella/microsome test plates.
    Stanton CA; Riley SE; Garner RC
    Mutat Res; 1984 Sep; 141(1):7-9. PubMed ID: 6482897
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hydroperoxidase I catalyzes peroxidative activation of 3,3'-dichlorobenzidine to a mutagen in Salmonella typhimurium.
    McGowan-Jordan IJ; Josephy PD
    Arch Biochem Biophys; 1990 Nov; 282(2):352-7. PubMed ID: 2241156
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Benzidine and 3,3'-dichlorobenzidine (DCB) induce micronuclei in the bone marrow and the fetal liver of mice after gavage.
    Cihák R; Vontorková M
    Mutagenesis; 1987 Jul; 2(4):267-9. PubMed ID: 3325756
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Aromatic amine DNA adduct formation in chronically-exposed mice: considerations for human comparison.
    Poirier MC; Beland FA
    Mutat Res; 1997 May; 376(1-2):177-84. PubMed ID: 9202754
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dose responses for DNA adduct formation in tissues of rats and mice exposed by inhalation to low concentrations of 1,3-[2,3-[(14)C]-butadiene.
    Booth ED; Kilgour JD; Robinson SA; Watson WP
    Chem Biol Interact; 2004 Mar; 147(2):195-211. PubMed ID: 15013821
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.